Glaukos shows that its new eye treatment lowers eye pressure better when used with cataract surgery.

Oct 9, 2026, 12:56 PM ETTrialRead the original at Benzinga

Good for GKOS

Eye pressure fell 11.1 mmHg with Glaukos’ implant plus cataract surgery, versus 7.4 mmHg with surgery alone. The report found no specified treatment-related eye problems over 3 months, but did not show how long the benefit lasts.

GKOS · Glaukos Corporation

AI read · Good for GKOS

The AI's read

These results suggest the implant could help Glaukos offer more effective care to patients who also need cataract surgery. The pressure drop was greater than with surgery alone, and the report found no specified treatment-related eye problems over 3 months. Longer-term results were not reported.

Get alerts for GKOS

Follow Glaukos Corporation (GKOS) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for GKOS

Free on the App Store and Google Play, or on the web.